Transaction in Own Shares

Summary by AI BETAClose X

Ryanair Holdings plc has announced its share buy-back activity for the period of April 6, 2026, to April 10, 2026, during which it purchased a total of 7,322 ordinary shares for cancellation at an average price of approximately €25.73 and 572,296 ordinary shares underlying American Depositary Shares at an average price of approximately US$30.75. These purchases are part of the company's ongoing share buy-back programme, with all acquired shares being cancelled.

Disclaimer*

Ryanair Holdings PLC
13 April 2026
 

Ryanair Holdings plc

Transactions in own shares

Ryanair Holdings plc (the "Company") announces that in the period 06 April 2026 to 10 April 2026 it purchased for cancellation in aggregate 7,322 ordinary shares of nominal value €0.006 each in the capital of the Company ("Ordinary Shares") and in aggregate 572,296 Ordinary Shares underlying the American Depositary Shares, as further detailed below.

Date

Number of Ordinary Shares

Volume weighted average price paid

Number of Ordinary Shares underlying American Depositary Shares

Volume weighted average price paid

06 April 2026

-

-

112,850

US $29.3047

07 April 2026

2,000

€24.231

115,224

US $28.9581

08 April 2026

2,000

€27.308

114,644

US $32.5245

09 April 2026

1,322

€25.731

115,262

US $31.4897

10 April 2026

2,000

€26.293

114,316

US $31.5047

 

These share purchases form part of the Company's existing share buy-back programme, details of which were announced on 20 May 2025 (the "Programme").  Purchases made under the share buyback programme will be announced on a weekly basis.

 

All shares purchased by the Company will be cancelled. This announcement is being made in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended. 

Issuer name:


Ryanair Holdings plc


LEI


635400BR2ROC1FVEBQ56

ISIN:


IE00BYTBXV33

 

Enquiries:

Contact:

Jamie Donovan

Ryanair Holdings Plc

Tel: + 353 1 945 1212

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings